Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model
Cong Yang, Yousheng Mo, Erjin Xu, et al.
International Immunopharmacology (2019) Vol. 75, pp. 105651-105651
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease
Chenyu Zhang, Miao Zhao, Bingwei Wang, et al.
Redox Biology (2021) Vol. 47, pp. 102134-102134
Open Access | Times Cited: 116
Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
Sandro Percário, Aline da Silva Barbosa, Everton Luiz Pompeu Varela, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-23
Open Access | Times Cited: 116
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Awanish Mishra, Ritam Bandopadhyay, Prabhakar Singh, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1591-1626
Closed Access | Times Cited: 98
Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2
Lan Xiao, Ziwei Dai, Wenjing Tang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 89
Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases
Pengwei Li, Mingxian Chang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7688-7688
Open Access | Times Cited: 88
Natural compounds modulate the autophagy with potential implication of stroke
Anil Ahsan, Mengru Liu, Yanrong Zheng, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 7, pp. 1708-1720
Open Access | Times Cited: 79
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
Yumin Wang, Luyan Gao, Jichao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 75
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 67
Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson’s disease
Elodie Kip, Louise C. Parr‐Brownlie
Ageing Research Reviews (2022) Vol. 78, pp. 101618-101618
Open Access | Times Cited: 53
Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Bora Tastan, Burak I. Ariöz, Şermin Genç
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Astragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases
Heba‐Tallah Abd Elrahim Abd Elkader, Amina E. Essawy, Ahmed S. Al‐Shami
Phytochemistry (2022) Vol. 202, pp. 113293-113293
Closed Access | Times Cited: 42
Astragaloside IV: A promising natural neuroprotective agent for neurological disorders
Min Yao, Lijuan Zhang, Lin Wang
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114229-114229
Open Access | Times Cited: 39
Metformin role in Parkinson’s disease: a double-sword effect
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 975-991
Closed Access | Times Cited: 39
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaser Hosny Ali Elewa, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2743-2759
Open Access | Times Cited: 36
Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36‐mediated ferroptosis
Xin Li, Ziwei Li, Xin Dong, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 3042-3056
Closed Access | Times Cited: 32
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 10
NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yiqun Yan, Yi Fang, Ran Zheng, et al.
Neuroscience (2020) Vol. 446, pp. 323-334
Open Access | Times Cited: 57
Nrf2 as a potential target for Parkinson’s disease therapy
Yingcai Niu, Jing Zhang, Miaoxian Dong
Journal of Molecular Medicine (2021) Vol. 99, Iss. 7, pp. 917-931
Closed Access | Times Cited: 43
The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine
Peng Chen, Jie Zhang, Chen Wang, et al.
Phytomedicine (2022) Vol. 100, pp. 154044-154044
Closed Access | Times Cited: 32
LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson’s disease
Jianzhong Zhang, Yunsheng Yang, Chaoyang Zhou, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 4493-4516
Open Access | Times Cited: 29
The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity
Jiaxue Chen, Jingke Xu, Ping Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112866-112866
Open Access | Times Cited: 29
Association of p53 with Neurodegeneration in Parkinson’s Disease
Qiang Luo, Wei Sun, Yifan Wang, et al.
Parkinson s Disease (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 28
Traditional Chinese medicine for treatment of sepsis and related multi-organ injury
Yaqin Song, Weiji Lin, Wen Zhu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Natural products for the treatment of neurodegenerative diseases
Donghan Cui, Yajuan Chen, Bengui Ye, et al.
Phytomedicine (2023) Vol. 121, pp. 155101-155101
Closed Access | Times Cited: 16
Role of NLRP3 in Parkinson's disease: Specific activation especially in dopaminergic neurons
Juan Yu, Zhanghong Zhao, Yuanyuan Li, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28838-e28838
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top